AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 191 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,133,000 | -41.9% | 60,954 | -46.2% | 0.01% | -33.3% |
| Q3 2019 | $3,671,000 | +28.1% | 113,306 | +97.3% | 0.01% | +20.0% |
| Q2 2019 | $2,865,000 | -73.1% | 57,440 | -75.1% | 0.01% | -76.2% |
| Q4 2018 | $10,638,000 | +77.0% | 230,710 | +196.1% | 0.04% | +162.5% |
| Q3 2018 | $6,009,000 | -52.1% | 77,918 | -47.6% | 0.02% | -56.8% |
| Q2 2018 | $12,536,000 | +12.9% | 148,830 | +9.6% | 0.04% | 0.0% |
| Q1 2018 | $11,106,000 | +264.7% | 135,807 | +155.0% | 0.04% | +270.0% |
| Q4 2017 | $3,045,000 | -10.3% | 53,265 | +4.8% | 0.01% | -16.7% |
| Q3 2017 | $3,393,000 | +1257.2% | 50,831 | +2159.2% | 0.01% | +1100.0% |
| Q2 2015 | $250,000 | – | 2,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |